复方丹参片辅助格列齐特缓释片、阿卡波糖片治疗2型糖尿病疗效观察

目的：研究复方丹参片辅助治疗2型糖尿病的临床效果。方法：选择104例糖尿病患者,随机分为对照组（n=51）,服用格列齐特缓释片、阿卡波糖片;治疗组（n=53）在对照组用西药格列齐特缓释片、阿卡波糖片的基础上加服复方丹参片,疗程8周。结果：对照组显效率64.2%,治疗组显效率82.3%,两组总有效率比较有显著差异（χ^2=5.58,P〈0.05）。结论：复方丹参片辅助治疗2型糖尿病的疗效良好,值得在临床推广。

Compound Danshen Tablets Assisting Gliclazide Sustained Release Tablets and Acarbose Tablets for Type 2 Diabetes: Observation of Curative Effect

OBJECTIVE： To study the clinical curative effect of Fufang Danshen Tablet as an adjunctive therapy for type 2 diabetes. METHODS： 104 patients with type 2 diabetes were enrolled： 51 （control group） were randomly assigned to receive Glielazide Sustained Release Tablets plus Aearbose Tablets for 8 weeks, and 53 （treatment group） to receive Gliclazide Sustained Release Tablets ＋ Acarbose Tablets in combination with Fufang Danshen Tablets for 8 weeks. RESULTS： The responsive rate was 64.2 % in control group versus 82.3 % in treatment group. There was significant difference in the total effective rate between the two groups （Χ^2 = 5.58, P 〈 0.05）. CONCLUSION： Fufang Danshen Tablet as an adjunctive therapy for type 2 diabetes achieved satisfactory curative effect, which thus deserved to be popularized in the clinic.